MUMBAI, Sept 27 (Reuters) - Biocon Ltd said on Monday it had strengthened its existing research partnership with Cuba-based Center of Molecular Immunology (CMI) to create a product pipeline focused on ...
Pharma major Biocon is set to announce its Q3FY26 results on 12 Feb 2026. Brokerage reports project a strong Q3FY26 for ...
Overall Count and Share for 'Biocon Bristol-Myers Squibb Research and Development Center (BBRC)' based on the 12-month time frame mentioned above. Note: Articles may be assigned to more than one ...
HYDERABAD (Reuters) - Indian drugmaker Biocon, looking to grab a piece of the exploding weight-loss drug market as early as possible, is developing its own version of Novo Nordisk's wildly popular ...
BANGALORE, April 19 (Reuters) - India's largest biotechnology firm, Biocon Ltd. , sees strong growth in the current fiscal year on new drug discovery and large research outsourcing services contracts, ...
As an update to our previous report, Biocon Biologics Ltd. (a subsidiary of Biocon Ltd.) announced the successful completion of the transition of the acquired biosimilars business in approximately 120 ...
BRIDGEWATER, N.J. and BENGALURU, India, Oct. 16, 2025 /PRNewswire/ -- Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE code: 532523, NSE: ...
Biocon Biologics, a subsidiary of Biocon, received a European Union GMP certificate from the Health Products Regulatory Authority (HPRA), Ireland, for its new monoclonal antibodies (mAbs) drug ...
Stocks to watch today: The stocks to watch today, 22 January 2026, include Eternal, InterGlobe Aviation, Eternal, Dr Reddy’s Laboratories, Biocon, Hindustan Petroleum Corporation Ltd (HPCL), CESC, ...
Article ‘Count’ and ‘Share’ for Biocon Bristol-Myers Squibb Research and Development Center (BBRC) based on listed parameters only. The articles listed below published by authors from Biocon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results